176 related articles for article (PubMed ID: 38789177)
21. Repurposing GLP1 agonists for neurodegenerative diseases.
Markaki I; Winther K; Catrina SB; Svenningsson P
Int Rev Neurobiol; 2020; 155():91-112. PubMed ID: 32854860
[TBL] [Abstract][Full Text] [Related]
22. Role of Novel Drug Delivery Systems in Coronavirus Disease-2019 (COVID-19): Time to Act Now.
Mittal N; Garg V; Bhadada SK; Katare OP
Curr Drug Deliv; 2021; 18(3):289-296. PubMed ID: 32938349
[TBL] [Abstract][Full Text] [Related]
23. Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease.
Johnston TH; Lacoste AMB; Visanji NP; Lang AE; Fox SH; Brotchie JM
Neuropharmacology; 2019 Mar; 147():11-27. PubMed ID: 29907424
[TBL] [Abstract][Full Text] [Related]
24. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
Kumar S; Chowdhury S; Kumar S
BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
[TBL] [Abstract][Full Text] [Related]
25. Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.
Nowak-Sliwinska P; Scapozza L; Ruiz i Altaba A
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):434-454. PubMed ID: 31034926
[TBL] [Abstract][Full Text] [Related]
26. Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation.
Arbo BD; Schimith LE; Goulart Dos Santos M; Hort MA
Eur J Pharmacol; 2022 Mar; 919():174800. PubMed ID: 35131314
[TBL] [Abstract][Full Text] [Related]
27. Artificial intelligence in COVID-19 drug repurposing.
Zhou Y; Wang F; Tang J; Nussinov R; Cheng F
Lancet Digit Health; 2020 Dec; 2(12):e667-e676. PubMed ID: 32984792
[TBL] [Abstract][Full Text] [Related]
28. Drug Repurposing During The COVID-19 Pandemic: Lessons For Expediting Drug Development And Access.
Greenblatt W; Gupta C; Kao J
Health Aff (Millwood); 2023 Mar; 42(3):424-432. PubMed ID: 36877896
[TBL] [Abstract][Full Text] [Related]
29. [Aiming for zero blindness].
Nakazawa T
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
[TBL] [Abstract][Full Text] [Related]
30. Drug Repositioning: A Monetary Stratagem to Discover a New Application of Drugs.
Rohilla A; Rohilla S
Curr Drug Discov Technol; 2024; 21(1):e101023222023. PubMed ID: 38629171
[TBL] [Abstract][Full Text] [Related]
31. Repurposing of biologics and biopharmaceuticals.
Israr J; Alam S; Singh V; Kumar A
Prog Mol Biol Transl Sci; 2024; 205():277-302. PubMed ID: 38789184
[TBL] [Abstract][Full Text] [Related]
32. Tackling Alzheimer's Disease with Existing Drugs: A Promising Strategy for Bypassing Obstacles.
Rampa A; Gobbi S; Belluti F; Bisi A
Curr Med Chem; 2021; 28(12):2305-2327. PubMed ID: 32867634
[TBL] [Abstract][Full Text] [Related]
33. Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
Bourdakou MM; Fernández-Ginés R; Cuadrado A; Spyrou GM
Redox Biol; 2023 Nov; 67():102881. PubMed ID: 37696195
[TBL] [Abstract][Full Text] [Related]
34. In silico drug repositioning: what we need to know.
Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
[TBL] [Abstract][Full Text] [Related]
35. A review on drug repurposing applicable to COVID-19.
Dotolo S; Marabotti A; Facchiano A; Tagliaferri R
Brief Bioinform; 2021 Mar; 22(2):726-741. PubMed ID: 33147623
[TBL] [Abstract][Full Text] [Related]
36. 'RE:fine drugs': an interactive dashboard to access drug repurposing opportunities.
Moosavinasab S; Patterson J; Strouse R; Rastegar-Mojarad M; Regan K; Payne PR; Huang Y; Lin SM
Database (Oxford); 2016; 2016():. PubMed ID: 27189611
[TBL] [Abstract][Full Text] [Related]
37. Considerations and challenges for sex-aware drug repurposing.
Fisher JL; Jones EF; Flanary VL; Williams AS; Ramsey EJ; Lasseigne BN
Biol Sex Differ; 2022 Mar; 13(1):13. PubMed ID: 35337371
[TBL] [Abstract][Full Text] [Related]
38. Recent Advances in Drug Repurposing for Parkinson's Disease.
Chen X; Gumina G; Virga KG
Curr Med Chem; 2019; 26(28):5340-5362. PubMed ID: 30027839
[TBL] [Abstract][Full Text] [Related]
39. Network medicine for disease module identification and drug repurposing with the NeDRex platform.
Sadegh S; Skelton J; Anastasi E; Bernett J; Blumenthal DB; Galindez G; Salgado-Albarrán M; Lazareva O; Flanagan K; Cockell S; Nogales C; Casas AI; Schmidt HHHW; Baumbach J; Wipat A; Kacprowski T
Nat Commun; 2021 Nov; 12(1):6848. PubMed ID: 34824199
[TBL] [Abstract][Full Text] [Related]
40. Repurposing old drugs to fight multidrug resistant cancers.
Dinić J; Efferth T; García-Sosa AT; Grahovac J; Padrón JM; Pajeva I; Rizzolio F; Saponara S; Spengler G; Tsakovska I
Drug Resist Updat; 2020 Sep; 52():100713. PubMed ID: 32615525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
